Cover Image

Multidrug-resistant tuberculosis today

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	A Matteelli (Author), R Centis (Author), L D'Ambrosio (Author), GB Migliori (Author)
Format:	Book
Published:	The World Health Organization, 2012-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Multidrug-resistant tuberculosis today
by: A Matteelli, et al.

Post-tuberculosis sequelae and their socioeconomic consequences: worth investigating
by: Giovanni Sotgiu, et al.
Published: (2021)

TUBERCULOSIS WITH MULTIDRUG-RESISTANT AND EXTENSIVELY DRUG-RESISTANT OF MICOBACTERIUM TUBERCULOSIS IN THE RUSSIAN FEDERATION
by: A.E. ERGESHOV, et al.
Published: (2018)

Scaling up multidrug-resistant tuberculosis care in China
by: Karen R Jacobson, et al.
Published: (2015)

Nomogram to predict multidrug-resistant tuberculosis
by: Saibin Wang, et al.
Published: (2020)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018)

Tuberculosis care and control
by: Philip C Hopewell, et al.
Published: (2006)

Tuberculosis care and control
by: Philip C Hopewell, et al.

Disadvantage and the experience of treatment for multidrug-resistant tuberculosis (MDR-TB)
by: Holly A. Taylor, et al.
Published: (2022)

Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis
by: Kai Blöndal

Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis
by: N. Yu. Nikolenko, et al.
Published: (2021)

Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia
by: Fanta Desissa, et al.
Published: (2018)

Representations on adherence to the treatment of Multidrug-Resistant Tuberculosis
by: Kuitéria Ribeiro Ferreira, et al.
Published: (2018)

Profile of delamanid for the treatment of multidrug-resistant tuberculosis
by: Szumowski JD, et al.
Published: (2015)

Young patient with complicated multidrug-resistant tuberculosis
by: Cristóbal Gallego Muñoz, et al.
Published: (2016)

Adolescence, multidrug resistant tuberculosis, bedaquine and videotapes
by: Anna Gamell, et al.
Published: (2023)

ANTITUBERCULOSIS DRUG ALLERGY IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS
by: B.B. MAYKANAEV, et al.
Published: (2021)

Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
by: Monadil H. Ali, et al.
Published: (2019)

Principles for designing future regimens for multidrug-resistant tuberculosis
by: Grania Brigden, et al.
Published: (2014)

Treatment Outcomes for Adolescents With Multidrug-Resistant Tuberculosis in Lima, Peru
by: Dylan B. Tierney MD MPH, et al.
Published: (2016)

Pediatric Multidrug-resistant Tuberculosis in Kyiv City, Ukraine
by: Silvia Shinpei Chiang, et al.
Published: (2019)

Predictive model of unfavorable outcomes for multidrug-resistant tuberculosis
by: Luiz Henrique Arroyo, et al.

The need to accelerate access to new drugs for multidrug-resistant tuberculosis
by: Helen S Cox, et al.
Published: (2015)

Multidrug-resistant tuberculosis detection and characterization of mutations in mycobacterium tuberculosis by genotype MTBDRplus
by: Rajneesh Tripathi, et al.
Published: (2017)

Main causes of chemotherapy inefficiency in patients with multidrug-resistant pulmonary tuberculosis
by: M. I. Sakhelashvili, et al.
Published: (2020)

Efficacy and Safety of Anti-Osteoporotic Agents across CKD Stages: A Meta-Analysis of Randomized Clinical Trials
by: Tahereh Sabaghian, et al.
Published: (2024)

FACTORS ASSOCIATED WITH THE OCCURRENCE OF PRIMARY MULTIDRUG-RESISTANT TUBERCULOSIS IN MEDAN
by: Rizky Aditya Hutomo, et al.
Published: (2024)

Multidrug-resistant tuberculosis in India: looking back, thinking ahead
by: Anthony T Fojo, et al.
Published: (2017)

Barriers faced by patients in the diagnosis of multidrug-resistant tuberculosis in Brazil
by: Marcela Bhering, et al.
Published: (2022)

New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline
by: Leibert E, et al.
Published: (2014)

Prevention of multidrug-resistant tuberculosis reactivity with using innovation technologies
by: Елена Ткач, et al.
Published: (2019)

Clofazimine as a Treatment for Multidrug-Resistant Tuberculosis: A Review
by: Rhea Veda Nugraha, et al.
Published: (2021)

Increased risk of hepatotoxicity and hyperuricemia in elderly Taiwanese multidrug-resistant tuberculosis patients taking pyrazinamide
by: D. Truong, et al.
Published: (2016)

Knowledge and practices about multidrug-resistant tuberculosis amongst healthcare workers in Maseru
by: Ntambwe Malangu, et al.
Published: (2015)

Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011
by: Hoa Binh Nguyen, et al.
Published: (2016)

Prevalence of drug-resistant recurrent tuberculosis and new multidrug-resistant tuberculosis mutations detection in Can Tho, Vietnam
by: Loan Thi Duong, et al.
Published: (2022)

Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework
by: Pablos-Méndez Ariel, et al.
Published: (2002)

Multidrug-Resistant Tuberculosis during Pregnancy: Two Case Reports and Review of the Literature
by: Minakshi Rohilla, et al.
Published: (2016)

Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: a case-control study
by: Maja Stosic, et al.
Published: (2018)

Linezolid resistance in multidrug-resistant mycobacterium tuberculosis: A systematic review and meta-analysis
by: Taher Azimi, et al.
Published: (2022)